| Dr Connie K Craig, PHD ARNP | |
|
14929 Se Allen Rd, Bellevue, WA 98006-1639 | |
| (425) 746-2124 | |
| (425) 746-2148 |
| Full Name | Dr Connie K Craig |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 14929 Se Allen Rd, Bellevue, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073601068 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PY00003200 (Washington) | Primary |
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | AP30004761 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Connie K Craig, PHD ARNP 7460 W Mercer Way, Mercer Island, WA 98040-5537 Ph: (206) 406-7539 | Dr Connie K Craig, PHD ARNP 14929 Se Allen Rd, Bellevue, WA 98006-1639 Ph: (425) 746-2124 |
News Archive
Amorcyte, Inc., a biopharmaceutical company developing cell therapy products to treat cardiovascular disease, today announced that it has been granted United States Patent number 7,794,705 titled "Compositions and Methods of Vascular Injury Repair." The patent contains both composition of matter and method claims surrounding therapeutic chemotactic hematopoietic stem cell products used in treating or repairing a vascular injury following an acute myocardial infarction (AMI), and delivery of the cell therapy.
A compound already used to treat pneumonia could become a new therapy for an inherited muscular wasting disease, according to researchers at the University of Oregon and the University of Rochester School of Medicine and Dentistry in New York.
Lannett Company, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the company's 505(b)(2) New Drug Application (NDA) for Morphine Sulfate Oral Solution on June 23, 2011.
The National Human Genome Research Institute (NHGRI) of the National Institutes of Health today announced an $8 million, three-year grant to establish a Wisconsin Center of Excellence in Genomics Science.
Concord Medical Services Holdings Limited, the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that effective as of July 1, 2010 it has entered into a joint venture with Chang'An Hospital for the operation of Chang'An Hospital's cancer treatment facilities by acquiring a 52% equity interest in Xi'an Wan Jie Hua Xiang Medical Technology Development Limited.
› Verified 4 days ago